CD27 and chronic graft versus host disease: Whereas patients after allogeneic HSCT have high numbers of CD19+IgD+CD27- naïve B cells, this B-cell subpopulation was significantly lower in individuals suffering from chronic graft-versus-host disease (cGvHD) (37).